Beta blockers

Practice tips for heart failure with reduced ejection fraction (HFrEF): supporting patients with medications and self-monitoring

Practice tips for heart failure with reduced ejection fraction (HFrEF): supporting patients with medications and self-monitoring

By Shari Hurst on April 6, 2022

There are a few tips and tricks to improve medication tolerance and adherence, and improve quality of life for patients with HF-rEF. Multiple studies have shown that a focus on patient education and empowerment along with clinical follow-up for HFrEF medical treatment improves survival, reduces hospitalizations, and improves quality of life.

Heart

Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction: The TOPCAT and ALDO-DHF trials

By Dr. Mustafa Toma and Dr. Christopher Cheung on May 27, 2015

There are approximately 500,000 Canadians living with heart failure, and more than 10% in patients older than 65. Up to 50% of patients presenting with signs and symptoms of heart failure will have a preserved ejection fraction (HFpEF or diastolic dysfunction). However, there is a lack of evidence for effective therapies in the management of HFpEF.

Aldosterone antagonists for the treatment of systolic heart failure

Aldosterone antagonists for the treatment of systolic heart failure

By Drs. Mustafa Toma and Neda Amiri on April 15, 2013

Spironolactone or eplerenone should be added to BB and ACEi/ARB in NYHA class II HF patients with EF < 30-35% in the absence of significant renal impairment or hyperkalemia.

Paradigm shift in treatment of hemangiomas

Paradigm shift in treatment of hemangiomas

By Dr. James Bergman on March 5, 2012

At present, for hemangiomas patients who I feel need systemic therapy I personally use oral Propanolol instead of systemic steroids, as I believe that the benefit risk analysis presently favours Propanolol.

Choosing antihypertensive combos: does it matter how you do it?

By Dr. Steve Wong on April 20, 2010

I generally started with thiazide diuretics (due to cost and proven effectiveness) then added either an ACE inhibitor (ACEi) or a calcium channel blocker (CCB), consistent with the Canadian Hypertension Society Guidelines.

Visit UBC CPD at ubccpd.ca

UBC CPD website

View all CPD learning activities: virtual, in-person and hybrid conferences, workshops, webinars, online modules, customized community courses, simulation hands-on courses, coaching, mentoring, personalized learning, recordings, and more.

Visit UBC CPD ↗

This field is for validation purposes and should be left unchanged.